Lv31
238 积分 2022-08-23 加入
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
2个月前
已完结
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
2个月前
已完结
PRR promotes hypertensive renal injury by activating Wnt/β-catenin signaling and inflammation infiltration in mice
2个月前
已完结
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series
3个月前
已完结
Recent advances in aerosol devices for the delivery of inhaled medications
3个月前
已关闭
Nephrotic syndrome: pathophysiology and consequences
3个月前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
3个月前
已完结
IgA nephropathy
3个月前
已完结
Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension
10个月前
已完结
皖公网安备34019202002308
